glp 1 market size share of GLP-1 RAs in 2016 and 2017 Glucagon Like Peptide-1 (GLP-1) Agonists
Description
Market growth is further supported by urbanization, the expansion of endocrinology and specialty clinics, and broader access to healthcare services
LegitScript Certification: The Gala GLP-1 website displays a LegitScript verification seal
10.1016/j.exer.2014.05.004
with a safety profile consistent with prior danuglipron studies including no liver enzyme elevations observed in more than 1,400 study participants
It works by inhibiting an enzyme called citrate lyase, which is involved in fat production in the body
These agents have also demonstrated additional metabolic benefits such as delayed gastric emptying and reduced appetite, which contribute to improved overall glycaemic outcomes and cardiometabolic health 7
